Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXO2TN
|
||||
| Drug Name |
4-[(4-Chlorophenyl)methyl]-2-{1-[4-(4-{[3-(hexahydro-1H-azepin-1-yl)propyl]oxy}phenyl)butyl]hexahydro-1H-azepin-4-yl}-1(2H)-phthalazinone
|
||||
| Synonyms |
CHEMBL1767161
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C40H51ClN4O2
|
||||
| Canonical SMILES |
Clc1ccc(CC2=NN(C3CCCN(CCCCc4ccc(OCCCN5CCCCCC5)cc4)CC3)C(=O)c6ccccc26)cc1
|
||||
| InChI |
InChI=1S/C40H51ClN4O2/c41-34-19-15-33(16-20-34)31-39-37-13-3-4-14-38(37)40(46)45(42-39)35-12-9-27-44(29-23-35)26-8-5-11-32-17-21-36(22-18-32)47-30-10-28-43-24-6-1-2-7-25-43/h3-4,13-22,35H,1-2,5-12,23-31H2
|
||||
| InChIKey |
QLOCEFPHCAKSLE-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Alpha-1 adrenergic receptor | Target Info | [1587926] | ||
| Histamine H1 receptor | Target Info | [1587926] | |||
| PANTHER Pathway | Histamine H1 receptor mediated signaling pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.